PEOPLE - Amorfix Life Sciences makes appointment:
This article was originally published in Clinica
William Lambert has been appointed to the board of directors of emerging neuro/degenerative theranostics company Amorfix Life Sciences (Toronto, Ontario). He replaces Donald Rix, who has resigned but continues to support the firm. Mr Lambert, who will also chair Amorfix's audit committee, is a special partner with private equity firm Birch Hill Equity Partners (Toronto).